General MedicationsINJECTIONStandard
NALLPEN IN PLASTIC CONTAINER
NAFCILLIN SODIUM
Standard Dose
EQ 2GM BASE/100ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview NALLPEN IN PLASTIC CONTAINER is listed in Drugs@FDA under application 050655 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient NAFCILLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/100ML Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2018-04-05 00:00:00.
Structured Monograph
Clinical summary
Approval overview NALLPEN IN PLASTIC CONTAINER is listed in Drugs@FDA under application 050655 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient NAFCILLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/100ML Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2018-04-05 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.